Human Biotechnology: Responding to Emerging Dangerous New Human Genetics
By Jesse Reynolds,
Z Magazine
| 03. 31. 2003
As 2003 began, the mainstream press was grappling with a cloning hoax. This January, it launched extended coverage of the 50th anniversary of the identification of DNA's structure. Both events provided golden opportunities to deepen public understanding of the social and political implications of new human genetic and reproductive technologies.
Unfortunately, the media have mostly flubbed these opportunities. The coverage of the Raelians' cloning claims obscured rather than illuminated the critical issues. Early signs on the second media opportunity-a series of carefully planned celebrations throughout the spring-are none too promising. Fortunately, a civil society response to dangerous new human genetic and reproductive technologies is emerging in a number of countries, as witnessed at January's World Social Forum in Brazil.
The year's first human biotechnology media frenzy actually began at the end of December 2002, when a previously obscure alien-chasing sect announced that its scientists had produced the world's first human clone. The initial news reaction appropriately focused on whether the claim could be true. But by the time the Raelians' excuses as to why they were unable to show the...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...